Reactions Weekly

, Volume 1697, Issue 1, pp 135–135 | Cite as

Dalbavancin/vancomycin

Development of drug resistance: case report
Case report
  • 17 Downloads

Reference

  1. Werth BJ, et al. Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimen. Clinical Microbiology and Infection 24: 429.e1-e5, No. 4, Apr 2018. Available from: URL: http://doi.org/10.1016/j.cmi.2017.07.028 - USACrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations